Pancreatic Cancer Research

ResearcherWuhan UniversityActive in the last 2 years

Fuxiang Zhou

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0001-9216-5395; OpenAlex author ID A5028677741.

Their work

Papers
3 (first author 0, last author 3)
Trials
1
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2020: 1 trial · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. The effects of radiotherapy and prognostic nomogram for pancreatic cancer patients with liver-only metastases Last author DOI 10.21203/rs.3.rs-3998524/v1↗
  2. The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective stud… Last author DOI 10.1186/s12957-023-02896-z↗
  3. Impact of Adjuvant Chemoradiotherapy on Survival of Resected Pancreatic Adenocarcinoma Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis. Last author DOI 10.3389/fonc.2021.651671↗

Trials 1

  1. High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors Study chair NCT04033107↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Miaomiao Liu · 1 shared paper, 2024
  2. Lei Yang · 1 shared paper, 2023
  3. Xiaomao Shi · 1 shared paper, 2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.